Lakhs of central government employees and pensioners have reason to track a new development closely. The official website of the 8th Central Pay Commission (CPC) has gone live at (https://8cpc.gov.in/ ...
10 Department of Sport and Sport Science, University of Freiburg, Freiburg, Germany Correspondence to Korakakis Vasileios, Department of Physical Education & Sport Science, University of Thessaly, ...
Background Metabolic dysfunction associated steatotic liver disease (MASLD), the most common chronic liver disease globally, may originate early in life. While maternal obesity is linked to offspring ...
Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.
Malnutrition and muscle loss are among the most underestimated complications of inflammatory bowel disease (IBD). 1-3 Despite guideline recommendations, routine clinical practice ...
Factors Associated with Venous Thromboembolic Disease in a Group of Sub-Saharan Afrcan Population Followed-Up for Cervical ...
A new study from researchers at the University of Liverpool and King's College London reveals that whilst women may value the ...
Pressure to achieve at school at age 15 is linked to depressive symptoms and risk of self-harm, and the association appears to persist into adulthood, finds a study led by University College London ...
Objective To investigate the associations of oxidative balance score (OBS) with all-cause mortality, cardiovascular mortality and cardiovascular disease (CVD) incidence in two large, population-based ...
Objective This study investigated perinatal depressive symptoms among pregnant and postpartum Filipino women. Design Cross-sectional survey. Setting The Philippines. Participants Participants were ...
As the MDGs era comes to a conclusion with the end of the year, 2016 ushers in the official launch of the bold and transformative 2030 Agenda for Sustainable Development adopted by world leaders last ...
Optune Pax concomitant with gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer Phase 3 PANOVA-3 trial showed a statistic ...